Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Philippe Guillet(Unknown), P. Nigel Leigh(University of Leeds), Vincent Meininger(Sorbonne Université), Lucette Lacomblez(Sorbonne Université), Gilbert Bensimon(Pitié-Salpêtrière Hospital)
Cited by 1,290
Related Papers
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
|New England Journal of Medicine|1994|2.2k
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
|Nature Genetics|2008|1.5k
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
|Nature Genetics|2016|633
Clinical consequences of corticectomies involving the supplementary motor area in man
|Journal of the Neurological Sciences|1977|561